Get started
Author

Yanina Ivashko‐Pachima

Observed names: Ivashko-Pachima, Yanina, Y Ivashco-Pachima, Y Ivashko-Pachima, Yanina Ivashko Pachima, Yanina Ivashko-Pachima, Yanina Ivashko-pachima
Institution: Tel Aviv University
Observed institution: Tel Aviv University
ORCID: 0000-0002-1773-7127
Observed ORCID: 0000-0002-1773-7127
OpenAlex ID: A5021651029
The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins
2014 · S Oz, O Kapitansky, et al. · Molecular Psychiatry · 142
Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study
2019 · Yanina Ivashko-Pachima, Adva Hadar, et al. · Molecular Psychiatry · 106
PDF
ADNP/NAP dramatically increase microtubule end-binding protein–Tau interaction: a novel avenue for protection against tauopathy
2017 · Y Ivashko-Pachima, C Laura Sayas, et al. · Molecular Psychiatry · 102
Tauopathy in the young autistic brain: novel biomarker and therapeutic target
2020 · Iris Grigg, Yanina Ivashko-Pachima, et al. · Translational Psychiatry · 100
PDF
The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
2012 · Saar Oz, Yanina Ivashko-Pachima, et al. · PLoS ONE · 86
PDF
Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation
2021 · Adva Hadar, Oxana Kapitansky, et al. · Molecular Psychiatry · 61
SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism
2022 · Yanina Ivashko-Pachima, Maram Ganaiem, et al. · Molecular Psychiatry · 58
NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies
2019 · Yanina Ivashko-Pachima, Maya Maor, et al. · PLoS ONE · 40
PDF
Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk
2022 · Maram Ganaiem, Gidon Karmon, et al. · Cells · 33
PDF
NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms
2023 · Maram Ganaiem, Nina D. Gildor, et al. · Cells · 30
PDF
ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect
2018 · Illana Gozes, Yanina Ivashko-Pachima, et al. · Frontiers in Molecular Neuroscience · 27
PDF
Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy
2020 · Yanina Ivashko-Pachima, Illana Gozes · Progress in molecular biology and translational science · 26
NAP Protects against Tau Hyperphosphorylation Through GSK3
2018 · Yanina Ivashko-Pachima, Illana Gozes · Current Pharmaceutical Design · 24
ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration
2015 · Illana Gozes, Yanina Ivashko-Pachima · Frontiers in Aging Neuroscience · 18
PDF
Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer’s Disease
2016 · Yanina Ivashko Pachima, Liu-yao Zhou, et al. · Journal of Molecular Neuroscience · 15
PDF
A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
2019 · Yanina Ivashko-Pachima, Illana Gozes · Frontiers in Cellular Neuroscience · 13
PDF
Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis
2020 · Yanina Ivashko-Pachima, Illana Gozes · Journal of Molecular Neuroscience · 12
PDF
Single-cell analysis of cytoskeleton dynamics: From isoelectric focusing to live cell imaging and RNA-seq
2019 · Illana Gozes, Yanina Ivashko-Pachima, et al. · Journal of Neuroscience Methods · 8
Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP
2021 · Yanina Ivashko-Pachima, Kim B. Seroogy, et al. · Journal of Molecular Neuroscience · 7
PDF
Extremely Low‐Frequency and Low‐Intensity Electromagnetic Field Technology (ELF‐EMF) Sculpts Microtubules
2025 · Alexandra Lobyntseva, Maram Ganaiem, et al. · European Journal of Neuroscience · 4
The thrombin receptor (PAR1) is associated with microtubules, mitosis and process formation in glioma cells
2024 · Valery Golderman, Shany Guly Gofrit, et al. · Heliyon · 3
Corrigendum: A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
2021 · Yanina Ivashko-Pachima, Illana Gozes · Frontiers in Cellular Neuroscience · 1
PDF
Long-Term Outcomes and Predictors of Postoperative Complications After Endoscopic Conjunctivodacryocystorhinostomy
2026 · Maxim Bez, Etti Katzburg, et al. · Ophthalmic Plastic and Reconstructive Surgery
Author response for "Extremely Low-Frequency and Low-Intensity Electromagnetic Field Technology (ELF-EMF) Sculpts Microtubules"
2025 · Lobyntseva, Alexandra, Ganaiem, Maram, et al.
Works count: 25
Citation count: 916
H-index: 15
I10-index: 17
Year
Topic
Type